Black Rock Inc. Genmab A/S Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Genmab A/S stock. As of the latest transaction made, Black Rock Inc. holds 5,067,133 shares of GMAB stock, worth $127 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,067,133

Previous 4,409,575 14.91%

Holding current value

$127 Million

Previous $140 Million 7.95%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$26.43 - $32.77 $17.4 Million - $21.5 Million	657,558 Added 14.91%	5,067,133 $152 Million
Q4 2023 Feb 13, 2024	SELL	$27.94 - $35.44 $11.4 Million - $14.5 Million	-407,844 Reduced 8.47%	4,409,575 $140 Million
Q3 2023 Nov 13, 2023	SELL	$35.27 - $42.24 $13.7 Million - $16.4 Million	-387,087 Reduced 7.44%	4,817,419 $170 Million
Q2 2023 Aug 11, 2023	SELL	$37.4 - $42.94 $1.62 Million - $1.86 Million	-43,354 Reduced 0.83%	5,204,506 $198 Million
Q1 2023 May 12, 2023	SELL	$34.88 - $43.22 $7.96 Million - $9.86 Million	-228,185 Reduced 4.17%	5,247,860 $198 Million

Q4 2022 Feb 13, 2023	BUY	$33.8 - $47.06 $6.97 Million - $9.7 Million	206,186 Added 3.91%	5,476,045 $232 Million
Q3 2022 Nov 14, 2022	SELL	$31.52 - $373.61 $5.51 Million - $65.3 Million	-174,904 Reduced 3.21%	5,269,859 $169 Million
Q2 2022 Aug 12, 2022	SELL	$26.83 - $38.57 $1.34 Million - $1.93 Million	-49,926 Reduced 0.91%	5,444,763 $177 Million
Q1 2022 May 12, 2022	BUY	$30.95 - $39.68 $2.68 Million - $3.44 Million	86,571 Added 1.6%	5,494,689 $199 Million
Q4 2021 Feb 10, 2022	SELL	$35.87 - $47.12 $51.9 Million - $68.2 Million	-1,446,846 Reduced 21.11%	5,408,118 $214 Million
Q3 2021 Nov 09, 2021	SELL	$41.55 - $48.72 $34.6 Million - $40.6 Million	-833,188 Reduced 10.84%	6,854,964 $300 Million
Q2 2021 Aug 11, 2021	BUY	$32.88 - $44.57 $253 Million - $343 Million	7,688,152 New	7,688,152 $314 Million

Others Institutions Holding GMAB

# of Institutions

241

Shares Held

47.6M

Call Options Held

31.3K

Put Options Held

38.7K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $16.5B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account